Standard BioTools(LAB) - 2020 Q2 - Earnings Call Presentation

Fluidigm Corporation Q2 2020 August 2020 FLUIDIGM® Forward-looking statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding market opportunities and growth rates, access to infectious disease, immuno-oncology and diagnostics markets, expected uses for and advantages of company products, including a COVID-19 assay that is under FDA review, implementation and expected results of st ...